Table 2. Substrate specificity of heterologous expressed bile salt hydrolases in Escherichia coli.
T-β-MCA1 | TCA | TCDCA | TDCA | GCA | GCDCA | |
---|---|---|---|---|---|---|
L. johnsonii LB1 BSHA | - | - | - | - | - | - |
L. johnsonii LB1 BSHB | +2 | + | + | + | + | + |
L. johnsonii LB1 BSHC | + | + | + | + | + | + |
L. johnsonii NCK88 BSHB | + | + | + | + | + | + |
L. johnsonii NCK88 BSHC | - | - | - | - | + | + |
L. johnsonii ATCC 33200 BSHA | - | - | - | - | - | - |
1 Bile acids are: T-β-MCA, tauro-beta-muricholic acid; TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; GCA, glycocholic acid; GCDCA, glycochenodeoxycholic acid.
2 Positive activity is defined as a mean 20% reduction in substrate concentration from three independent assays.